Synairgen (SYNG)

Currency in GBP
0.01
0.00(0.00%)
Closed·
Showing Synairgen historical data. For real-time data please try another search
Fair Value
Day's Range
0.010.01
52 wk Range
0.018.00
Key Statistics
Bid/Ask
0.60 / 1.00
Prev. Close
0.95
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-8
Volume
-
Average Volume (3m)
1.66M
1-Year Change
-99.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SYNG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Synairgen News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Compare SYNG to Peers and Sector

Metrics to compare
SYNG
Peers
Sector
Relationship
P/E Ratio
0.0x−5.6x−0.5x
PEG Ratio
0.000.050.00
Price/Book
0.0x3.7x2.6x
Price / LTM Sales
0.0x10.6x3.2x
Upside (Analyst Target)
0.0%110.7%43.8%
Fair Value Upside
Unlock16.9%5.1%Unlock

Earnings

Latest Release
Mar 13, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SYNG Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.